<DOC>
	<DOCNO>NCT00546468</DOCNO>
	<brief_summary>Rationale : For treatment early gastric cancer ( EGC ) distal portion stomach , subtotal gastrectomy lymph node dissection standard operation . With increase tendency toward minimally invasive surgery , effort apply minimally invasive technique treatment EGC . Laparoendoluminal mucosectomy lesion-lifting gastric wedge resection develop purpose . However , method disadvantage limit indication accord size , shape depth invasion . Kitano et al . perform first laparoscopy-assisted subtotal gastrectomy lymph node dissection manual anastomosis anterior wall lift method patient EGC . In 1995 , Uyama et al . Nagai et al . perform laparoscopy-assisted subtotal gastrectomy lymph node dissection use automatic stapler instead manual anastomosis gastroduodenal anastomosis . It possible maintain adequate distance lesion proximal distal margin resection , perform radical lymph node dissection , achieve excellent postoperative recovery . However , limited evidence superiority laparoscopic gastrectomy open surgery . There one interim report randomize clinical trial compare laparoscopic gastrectomy open gastrectomy . A well-designed clinical study prove benefit safety definitely need Objective : compare Laparoscopy - assist Distal Gastrectomy ( LADG ) Open Distal Gastrectomy ( ODG ) term survival , recovery , pain , complication , quality life ( QOL ) Hypothesis : LADG beneficial QOL , pain , recovery , complication maintain equivalent survival ODG</brief_summary>
	<brief_title>Clinical Study Laparoscopic Gastrectomy Early Gastric Cancer ( COACT_0301 )</brief_title>
	<detailed_description>1 . Randomization Randomization do person involve study . So do person Center Clinical Trial National Cancer Center . The patient enrol out-patient clinic get informed consent clinical study patient . Surgeon factor consider randomization factor clinical study perform intramurally . In Center Gastric Cancer , National Cancer Center , Surgical techniques extent resection generally standardize surgical outcome term complication recovery . 2 . Follow-up schedule Patients follow outpatient department four week , three month , six month , twelve month operation , every six month thereafter . On visit , history review physical examination do . A complete blood count ( CBC ) serum chemistry evaluate also . An esophago-gastro-duodenoscopy ( EGD ) perform three month operation yearly thereafter . Abdominal compute tomography ( ACT ) evaluate annually . 3 . Assessment QOL The European EORTC QLQ-C30 ( version 3.0 ) questionnaire 30-item cancer-specific integrated system assess health-related QOL cancer patient . The questionnaire incorporate five scale function ( physical , role , cognitive , emotional social ) , three symptom scale ( fatigue , pain nausea vomit ) , global health QOL scale , single item assessment additional symptom commonly report cancer patient ( e.g. , dyspnea , appetite loss , sleep disturbance , constipation diarrhea ) , well perceive financial impact disease treatment . All item score four-point Likert scale , exception two item global health QOL scale , use modify seven-point linear analog scale . The EORTC QLQ-STO22 22-item stomach cancer-specific questionnaire also use . It incorporate five hypothesize scales— ( dysphasia , eat restriction , pain , reflux anxiety ) four single item ( dry mouth , body image , taste , hair loss ) cover disease treatment-related symptom specific emotional consequence gastric cancer.12 All instrument questionnaire administer preoperatively postoperatively seven day , 30 day , 90 day yearly . Those time point choose usual follow-up schedule every gastrectomized patient institute , maximize compliance questionnaire , compare parameter time . 4 . Statistical analyse The EORTC QLQ-C30 symptom subscale EORTC QLQ-STO22 subscale score report use scale 0 100 . Statistical analysis QOL outcomes evaluate difference LADG ODG group respect overall change preoperative score ( baseline ) obtain follow-up . To adjust possible baseline difference , include baseline value model . All comparison group base 'intent-to-treat ' analysis patient analyze accord assigned treatment group . Categorical variable compare use χ2 test , continuous variable analyze use Student 's t-test . Analysis Covariance ( ANCOVA ) repeat measure use compare two group patient respect overall change short term quality life surgery . The SAS ( SAS Institute Inc. , Cary , NC , USA ) program call 'PROC GLM ' use .</detailed_description>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<criteria>Histologically confirm adenocarcinoma stomach Age : 1880 year Performance status : ECOG 01 Informed consent sign EGD find early gastric cancer EUS find mucosa submucosa cancer The location tumor antrum , angle , low body great curvature UGIS No evidence distant metastasis abdomen CT , chest PA Regional lymph node metastasis confine perigastric node ( N1 ) CT EUS Any comorbidity obviate major surgery Contraindication laparoscopy : severe cardiac disease , abdominal wall hernia , diaphragmatic hernia , uncorrected coagulopathies , portal hypertension , pregnancy Previous upper abdominal operation Indication EMR : well moderately differentiate adenocarcinoma , less 2 cm EGC type I IIa , less 1cm EGC type IIb IIc , ulceration Complicated case need get emergency operation Any accompany surgical condition need perform time</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>stomach cancer</keyword>
	<keyword>laparoscopy</keyword>
	<keyword>gastrectomy</keyword>
	<keyword>QOL</keyword>
	<keyword>survival</keyword>
	<keyword>clinical study</keyword>
</DOC>